SPL fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Starpharma Holdings Ltd. engages in the research, development, and commercialization of dendrimer products for pharmaceutical and healthcare applications. Its pipeline and products include SN38, cabazitaxel, docetaxel, radiopharmaceuticals, antibody-drug conjugates, and anti-infective products. The company was founded in 1996 and is headquartered in Abbotsford, Australia.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
SPL does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company